Drommi, F.; Calabrò, A.; Pezzino, G.; Vento, G.; Freni, J.; Costa, G.; Cavaliere, R.; Bonaccorsi, I.; Allegra, A.; Ferlazzo, G.;
et al. Multiple Myeloma Cells Shift the Fate of Cytolytic ILC2s Towards TIGIT-Mediated Cell Death. Cancers 2025, 17, 263.
https://doi.org/10.3390/cancers17020263
AMA Style
Drommi F, Calabrò A, Pezzino G, Vento G, Freni J, Costa G, Cavaliere R, Bonaccorsi I, Allegra A, Ferlazzo G,
et al. Multiple Myeloma Cells Shift the Fate of Cytolytic ILC2s Towards TIGIT-Mediated Cell Death. Cancers. 2025; 17(2):263.
https://doi.org/10.3390/cancers17020263
Chicago/Turabian Style
Drommi, Fabiana, Alessia Calabrò, Gaetana Pezzino, Grazia Vento, Josè Freni, Gregorio Costa, Riccardo Cavaliere, Irene Bonaccorsi, Alessandro Allegra, Guido Ferlazzo,
and et al. 2025. "Multiple Myeloma Cells Shift the Fate of Cytolytic ILC2s Towards TIGIT-Mediated Cell Death" Cancers 17, no. 2: 263.
https://doi.org/10.3390/cancers17020263
APA Style
Drommi, F., Calabrò, A., Pezzino, G., Vento, G., Freni, J., Costa, G., Cavaliere, R., Bonaccorsi, I., Allegra, A., Ferlazzo, G., De Pasquale, C., & Campana, S.
(2025). Multiple Myeloma Cells Shift the Fate of Cytolytic ILC2s Towards TIGIT-Mediated Cell Death. Cancers, 17(2), 263.
https://doi.org/10.3390/cancers17020263
